Speak with our HG Experts

To contact the HER Foundation for interviews, please email media@hyperemesis.org.

HG women in your area

To find women around the world willing to share their stories to help raise awareness of HG, please email media@hyperemesis.org.

Media Relations Contacts

Please direct media inquiries to media@hyperemesis.org.

Our HG Experts

Dr. Marlena Fejzo, a Harvard-trained women's health researcher, specializing in genetics, an affiliated with the University of Southern California. Dr. Fejzo is credited with discovering the cause of HG and is the world's leading research scientist on HG and a HER Foundation Board member and Research Advisor. Dr. Fejzo endured HG during her pregnancies. Email her at research at hyperemesis.org.

Dr. Aimee Brecht-Doscher is an OBGYN in the Los Angeles area who has personally been affected by HG. She is a HER Foundation Board member and the Medical Advisor for the Foundation. Email her at aimee at hyperemesis.org.

Kimber MacGibbon is a registered nurse (RN) and has helped many thousands of families facing HG across the globe since 2000. She has an extensive understanding of HG from a medical, advocacy, and personal perspective. Kimber is also co-founder of the HER Foundation. She and Dr. Fejzo have co-authored over three dozen publications on HG in collaboration with universities, including USC and UCLA. Kimber had HG in both of her pregnancies and is located in Portland, Oregon. Email her at kimber at hyperemesis.org.

Nausea Strategies in HG

By HER Foundation | March 6, 2023

While some medications target vomiting (ondansetron/Zofran), there are no medications that specifically target nausea. Some medications used to treat Hyperemesis Gravidarum (HG) may help reduce nausea but rarely will medications eliminate all nausea. Since there are numerous causes of nausea, treating as many as possible is most effective. This list of strategies may help reduce nausea depending on what is triggering symptoms. None works for everyone, but each may help a little.

Gen

Highlights of SMFM 2023 Medical Conference

By HER Foundation | February 20, 2023

Overall, this study contributes to our understanding of the biology of nausea and vomiting in pregnancy and may lead to future research evaluating new treatment avenues. Of note, drugs targeting the GDF15 pathway have shown great promise in mitigating weight loss, loss of appetite, and vomiting in animal models and are currently in clinical trials in cancer cachexia, a disease with similar symptoms to HG.

Complications Secondary to Hyperemesis Gravidarum (HG)

By HER Foundation | February 16, 2023

Hyperemesis Gravidarum (HG) is not self-limiting, and its impact can last a lifetime for mothers and their children. Until there is recognition of this fact and comprehensive, universal, effective treatment for all HG patients, every level of society will continue to face the costs of HG.

sick mother in bed
IMG_7597-min
Woman getting Physical Therapy
Copy of F cus 1-min
HG baby
frustrated mom and baby